In vivo biodistribution and accumulation of 89Zr in mice
- 31 July 2011
- journal article
- Published by Elsevier BV in Nuclear Medicine and Biology
- Vol. 38 (5), 675-681
- https://doi.org/10.1016/j.nucmedbio.2010.12.011
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- 89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In VivoJournal of Nuclear Medicine, 2010
- Cerenkov Luminescence Imaging of Medical IsotopesJournal of Nuclear Medicine, 2010
- Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPETNuclear Medicine and Biology, 2010
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast CancerClinical Pharmacology & Therapeutics, 2010
- p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-TrastuzumabPLOS ONE, 2010
- Standardized methods for the production of high specific-activity zirconium-89Nuclear Medicine and Biology, 2009
- Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET ImagingJournal of Nuclear Medicine, 2009
- A facile method for the labeling of proteins with zirconium isotopesNuclear Medicine and Biology, 1996
- Differences in the Distribution of Zirconium-95 and Niobium-95 in the RatNature, 1964